Hospitalizations due to preventable adverse reactions—a systematic review Nidhi S. PatelTejas K. PatelCB Tripathi Review 02 December 2016 Pages: 385 - 398
Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury Sukumaran SanjayChandrashekaran Girish Review 27 December 2016 Pages: 399 - 407
Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials Kerstin Breithaupt-GroeglerChristoph CochGeorg Wensing Review Open access 07 January 2017 Pages: 409 - 416
Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group Günther KrumplIvan UlcJuri Hodisch Clinical Trial 13 January 2017 Pages: 417 - 428
Medical students’ medication communication skills regarding drug prescription—a qualitative analysis of simulated physician-patient consultations Katarina HauserJan Matthes Clinical Trial 14 January 2017 Pages: 429 - 435
Platelet receptor Gene (P2Y12, P2Y1) and platelet glycoprotein Gene (GPIIIa) polymorphisms are associated with antiplatelet drug responsiveness and clinical outcomes after acute minor ischemic stroke Xingyang YiQiang ZhouCheng Fu Pharmacogenetics 13 January 2017 Pages: 437 - 443
Population pharmacokinetic models of lamotrigine in different age groups of Chinese children with epilepsy Zhong-bin ZhangShuang-min JiYe Wu Pharmacokinetics and Disposition 07 January 2017 Pages: 445 - 453
Effects of a primary care intervention to improve the quality of zolpidem prescriptions in elderly patients Rocío López-SepúlvedaMaría Ángeles García LirolaJosé Cabeza Barrera Pharmacoepidemiology and Prescription 27 December 2016 Pages: 455 - 461
Safety of zidovudine/lamivudine scored tablets in children with HIV infection in Europe and Thailand The European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord Pharmacoepidemiology and Prescription Open access 27 December 2016 Pages: 463 - 468
Erratum to: Safety of zidovudine/lamivudine scored tablets in children with HIV infection in Europe and Thailand The European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord Erratum 15 February 2017 Pages: 469 - 469
Does substitution of brand name medications by generics differ between pharmacotherapeutic classes? A population-based cohort study in France Alicia MolinierAurore PalmaroHaleh Bagheri Pharmacoepidemiology and Prescription 29 December 2016 Pages: 471 - 477
Six-year activity on approval of compassionate use of medicines by the Ethics Committee of the University Hospital of Bologna (Italy): time to update rules and recommendations Nicola MontanaroMauro MelisDomenico Motola Pharmacoepidemiology and Prescription 29 December 2016 Pages: 479 - 485
Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies A BiffiL ScottiG Corrao Pharmacoepidemiology and Prescription 09 January 2017 Pages: 487 - 497
Clinical relevance of the STOPP/START criteria in hip fracture patients Johan LönnbroSusanna M. Wallerstedt Pharmacoepidemiology and Prescription Open access 03 January 2017 Pages: 499 - 505
Can systematic reviews contribute to regulatory decisions? Corrado BarbuiAntonio AddisSilvio Garattini Point of View 07 January 2017 Pages: 507 - 509
Seizure and tetany secondary to hypomagnesaemic hypoparathyroidism induced by a proton-pump inhibitor Luca PasinaDanilo ZanottaGuido Bonoldi Letter to the Editor 28 November 2016 Pages: 511 - 512
Network meta-analysis as a tool for improving the effectiveness assessment of biosimilars based on both direct and indirect evidence: application to infliximab in rheumatoid arthritis Andrea MessoriSabrina TrippoliClaudio Marinai Letter to the Editor 14 December 2016 Pages: 513 - 514
Acute methotrexate toxicity presenting with bullous lesions: an unusual presentation Sarita SankePravesh YadavJagdish Chandra Letter to the Editor 14 December 2016 Pages: 515 - 516